Safety, Pharmacodynamics and Pharmacokinetics After Single Oral Administration of Dabigatran Etexilate Capsule in Healthy Subjects

NCT02171455 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Dabigatran etexilate low dose
DRUG: Dabigatran etexilate medium dose
DRUG: Dabigatran etexilate high dose
DRUG: Placebo

Sponsor

Boehringer Ingelheim